Using paired molecular and antibody testing for SARS-CoV-2 infection, we determined
point prevalence and
seroprevalence in a municipality in
Louisiana, USA during the second phase of reopening.
Infections were highly variable by
race,
work environment, and ZIP code.
Census-weighted
seroprevalence and
point prevalence were 3.6% and 3.0%, respectively.